Evidence map›Paper›PMID 38615059›Full record

ArticleScientific reports2024

Non-preventable cases of breast, prostate, lung, and colorectal cancer in 2050 in an elimination scenario of modifiable risk factors.

Frederik Knude Palshof, Lina Steinrud Mørch, Brian Køster, Gerda Engholm, Hans Henrik Storm, Therese M-L Andersson, Niels Kroman

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. A One Health Perspective on Cancer: A Narrative Review.Medical sciences (Basel, Switzerland) · 2026
    Review
  2. Integrating Knowledge of Modifiable and Non-modifiable Risk Factors: A Comprehensive Framework for Breast Cancer Prevention Practices in Women.Journal of cancer education : the official journal of the American Association for Cancer Education · 2026
    Observational
  3. Selective cytotoxicity ofFrontiers in pharmacology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Frederik Knude PalshofDanish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark. fkp@cancer.dk.
Lina Steinrud MørchDanish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark.
Brian KøsterDanish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark.
Gerda EngholmDanish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark.
Hans Henrik StormDanish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark.
Therese M-L AnderssonDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Niels KromanDanish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark.
Danish Cancer Society · DKKarolinska Institutet · SE

Funding

Kræftens Bekæmpelse R328-A18803
6 · The paper itself

Abstract

Most Western countries have increasing number of new cancer cases per year. Cancer incidence is primarily influenced by basically avoidable risk factors and an aging population. Through hypothetical elimination scenarios of multiple major risk factors for cancer, we estimated the number of new cancer cases that are non-preventable in 2050. We compare numbers of new postmenopausal breast, prostate, lung, and colorectal cancer cases in 2021 to projected numbers of new cases in 2050 under prevention scenarios regarding smoking, overweight and obesity, and alcohol consumption: no intervention, 50%, and 100% instant reduction. Cancer incidence data were derived from NORDCAN, and risk factor prevalence data from the Danish National Health Survey. Cancer projections were calculated with the Prevent program. Hypothetical 100% instant elimination of major risk factors for cancer in Denmark in 2022 will result in unchanged numbers of new breast and colorectal cancers in 2050. The number of new prostate cancers will increase by 25% compared to 2021. Unchanged risk factor levels will result in noticeable increase in cancer burden. Increase in life expectancy and age will entail an increase in cancer incidence, despite maximum effect of preventive actions in the population. Our results are important when planning future health care.

Indexed as

Colorectal NeoplasmsProstatic NeoplasmsAgedHumansLungMaleProstateRisk Factors

Identifiers

PMID38615059
PMCPMC11016117
OpenAlexW4394785791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.